RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3058% above fair value
$71.82−3.10 (-4.14%)
Close on Nov 18, 2026Market cap $5.65BP/E –Yield –
RadNet net income
Net income is the profit left for shareholders after every expense, interest and tax.
RadNet's net income for the twelve months ending Jun 30, 2026 was -$21.12M. For fiscal 2025 it was -$18.65M, down 767.8% from the year before. The highest annual figure on record is $32.24M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.65M | -767.8% |
| FY2024 | Dec 31, 2024 | $2.79M | -8.2% |
| FY2023 | Dec 31, 2023 | $3.04M | -71.4% |
| FY2022 | Dec 31, 2022 | $10.65M | -56.9% |
| FY2021 | Dec 31, 2021 | $24.73M | – |
| FY2020 | Dec 31, 2020 | -$14.84M | -200.6% |
| FY2019 | Dec 31, 2019 | $14.76M | -54.2% |
| FY2018 | Dec 31, 2018 | $32.24M | +60735.8% |
| FY2017 | Dec 31, 2017 | $53.00K | -99.3% |
| FY2016 | Dec 31, 2016 | $7.23M | -6.2% |
| FY2015 | Dec 31, 2015 | $7.71M | -27.7% |
| FY2014 | Dec 31, 2014 | $10.66M | -7.6% |
| FY2013 | Dec 31, 2013 | $11.54M | -6.9% |
| FY2012 | Dec 31, 2012 | $12.39M | +54.7% |
| FY2011 | Dec 31, 2011 | $8.01M | -4.5% |
| FY2010 | Dec 31, 2010 | $8.39M | – |
| FY2009 | Dec 31, 2009 | -$2.27M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.53M | -47.9% |
| Q1 FY2026 | Mar 31, 2026 | -$33.47M | – |
| Q4 FY2025 | Dec 31, 2025 | -$597.00K | -111.2% |
| Q3 FY2025 | Sep 30, 2025 | $5.42M | +68.8% |
| Q2 FY2025 | Jun 30, 2025 | $14.45M | – |
| Q1 FY2025 | Mar 31, 2025 | -$37.93M | – |
| Q4 FY2024 | Dec 31, 2024 | $5.35M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.21M | -81.7% |
| Q2 FY2024 | Jun 30, 2024 | -$2.98M | -135.6% |
| Q1 FY2024 | Mar 31, 2024 | -$2.78M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.86M | – |
| Q3 FY2023 | Sep 30, 2023 | $17.54M | +2525.7% |
| Q2 FY2023 | Jun 30, 2023 | $8.37M | +5.9% |
| Q1 FY2023 | Mar 31, 2023 | -$21.01M | -797.1% |
| Q4 FY2022 | Dec 31, 2022 | -$935.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $668.00K | -95.9% |
| Q2 FY2022 | Jun 30, 2022 | $7.91M | +175.1% |
| Q1 FY2022 | Mar 31, 2022 | $3.01M | -68.1% |
| Q4 FY2021 | Dec 31, 2021 | -$3.82M | -164.2% |
| Q3 FY2021 | Sep 30, 2021 | $16.22M | +163.5% |
| Q2 FY2021 | Jun 30, 2021 | $2.87M | – |
| Q1 FY2021 | Mar 31, 2021 | $9.46M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.96M | -42.7% |
| Q3 FY2020 | Sep 30, 2020 | $6.16M | +92.7% |
| Q2 FY2020 | Jun 30, 2020 | -$10.59M | -316.2% |
| Q1 FY2020 | Mar 31, 2020 | -$16.36M | – |
| Q4 FY2019 | Dec 31, 2019 | $10.40M | -64.3% |
| Q3 FY2019 | Sep 30, 2019 | $3.20M | -36.6% |
| Q2 FY2019 | Jun 30, 2019 | $4.90M | -9.4% |
| Q1 FY2019 | Mar 31, 2019 | -$3.73M | – |
| Q4 FY2018 | Dec 31, 2018 | $29.14M | – |
| Q3 FY2018 | Sep 30, 2018 | $5.04M | +56.1% |
| Q2 FY2018 | Jun 30, 2018 | $5.41M | +1.8% |
| Q1 FY2018 | Mar 31, 2018 | -$7.34M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.28M | -297.7% |
| Q3 FY2017 | Sep 30, 2017 | $3.23M | +96.1% |
| Q2 FY2017 | Jun 30, 2017 | $5.31M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.21M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.68M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.65M | – |
See a number that looks wrong?